Part 2 Fees relating to marketing authorisationsF1

United Kingdom Repealed

1. 7Fees for specified pharmaceutical applications
2. 8Decentralised pharmaceutical application where the United Kingdom is the reference Member State
3. 9Application for a marketing authorisation for an immunological product
4. 10Decentralised immunological application where the United Kingdom is the reference Member State
5. 11Application for a marketing authorisation using identical data
6. 12Application for an exceptional marketing authorisation (pharmaceutical)
7. 13Fees for an application for an exceptional marketing authorisation (immunological)
8. 14Fee for the conversion from an exceptional to a full marketing authorisation
9. 15Application for a marketing authorisation relating to a parallel import
10. 16Application to change the distribution category of a product authorised through the centralised procedure
11. 17Application for a variation to a marketing authorisation dealt with under national or mutual recognition variation procedures.
12. 18Application for a variation to a marketing authorisation dealt with under worksharing procedures
13. 19Application for an extension dealt with under the decentralised procedure where the United Kingdom is the reference Member State
14. 20Provision of information relating to the recognition of a United Kingdom marketing authorisation or an extension
15. 21Exception for a variation relating to animal testing
16. 22Application for the renewal of a national marketing authorisation
17. 23Application for the renewal of a marketing authorisation obtained through mutual recognition or the decentralised procedure
18. 24Registration of a homeopathic remedy
19. 25Annual fees for marketing authorisations
20. 26Auditor’s certificate